Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...
Stocktwits on MSN
Novo Nordisk to launch Ozempic pills following flat growth in diabetes segment in 2025
A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...
The Trump administration launched TrumpRx.gov on Thursday (February 5, 2026), a website designed to help Americans purchase ...
Novo Nordisk predicts a challenging 2026.
Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's ...
7don MSN
Beyond the brand names: Everything you need to know about Ozempic and other GPL-1 medications
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the ...
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results